AlloVir Total Non Current Liabilities 2011-2026 | ALVR

Annual Total Non Current Liabilities AlloVir

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	5.46 M	182 M	52.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
182 M	5.46 M	79.8 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	101 M	$ 217.74	-0.15 %	$ 5 B	Danmark
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 19.06	-0.88 %	$ 891 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	7.22 B	$ 7.66	-0.39 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.41	0.36 %	$ 360 M	Britain
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	42.1 M	$ 2.63	-	$ 16.5 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Genmab A/S GMAB	769 M	$ 25.48	-0.78 %	$ 16.5 B	Danmark
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Halozyme Therapeutics HALO	388 M	$ 61.63	-1.96 %	$ 7.39 B	USA
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.25	-3.85 %	$ 814 M	Canada
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
Harmony Biosciences Holdings HRMY	149 M	$ 27.15	-1.63 %	$ 1.56 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Завод ДИОД DIOD	89.5 M	-	-	-	Russia
Фармсинтез LIFE	13.2 M	-	-	-	Russia